How to optimize clinical trials in the commercial context
Elpis Barons, CEO Trajan Accelerator Group, shared her experience about optimizing clinical trials, at the Devices and Diagnostics Lab on 15 March 2017 at The Auditorium @ 452 Flinders, Melbourne, Victoria, Australia.
Ms Barons joined ten other speakers, five expert panelists and four dynamic chair people to address innovation in medical devices with a focus on implantable medical technologies.
Complementing her role at Trajan, Ms Barons also provides clinical research consulting services to international medical technology organizations, device manufacturers and suppliers, as Director of Barons Medical Consulting.
Ms Barons explored the commercial context of clinical trials, and how to leverage international networks to provide input into clinical trial designs that will generate value beyond regulatory approval, and provide supporting data to cause the adoption of medical devices.
The event was hosted by BioMelbourne Network and supported by the Victorian State Government, CSIRO, Piper Alderman, and the Australian Government Department of Industry, Innovation and Science. It was a great opportunity for discussion between business leaders, entrepreneurs, investors, clinicians, researchers, product developers and industry experts across medical technology, ICT, engineering, design, manufacturing and health innovation.
You can download the presentation at the Barons Medical Consulting website.
More information
BioMelbourne Network Devices + Diagnostics Lab
Barons Medical Consulting
Media contact information
Tel: +44 (0) 1244 403 100
media@trajanscimed.com
Also in News
Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.
Trajan collaborates with Monash University for the development of HDX training centre
